Kimihiro Kawakami
Takamatsu, 7608557, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Efficacy and side-effect profile of tedizolid in the treatment of streptococcal toxic shock syndrome due to clindamycin-resistant Streptococcus pyogenes: A case report.
Journal: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy
Published: September 05, 2023
Oncolytic Virus Therapy with HSV-1 for Hematological Malignancies.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: April 08, 2020
A Case of Tyrosine Kinase Inhibitor-Resistant Chronic Myeloid Leukemia, Chronic Phase with ASXL1 Mutation.
Journal: Case reports in oncology
Published: February 07, 2020
Regulatory T cell inhibition by dasatinib is associated with natural killer cell differentiation and a favorable molecular response-The final results of the D-first study.
Journal: Leukemia research
Published: November 11, 2017
The Pathogen of Brain and Hepatic Abscess was Successfully Determined by Molecular Biological Method in a Case of High Risk Acute Lymphoblastic Leukemia
Journal: Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine
Published: August 01, 2016
Association of pleural effusion with an early molecular response in patients with newly diagnosed chronic-phase chronic myeloid leukemia receiving dasatinib: Results of a D-First study.
Journal: Oncology reports
Published: April 22, 2016
Charlson comorbidity index predicts poor outcome in CML patients treated with tyrosine kinase inhibitor.
Journal: International journal of hematology
Published: March 20, 2016
The Leading Seafood Cuisine of Anisakidosis in Japan.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: March 16, 2016
Early cytotoxic lymphocyte expansion contributes to a deep molecular response to dasatinib in patients with newly diagnosed chronic myeloid leukemia in the chronic phase: results of the D-first study.
Journal: American journal of hematology
Published: June 16, 2015
Shorter halving time of BCR-ABL1 transcripts is a novel predictor for achievement of molecular responses in newly diagnosed chronic-phase chronic myeloid leukemia treated with dasatinib: Results of the D-first study of Kanto CML study group.
Journal: American journal of hematology
Published: December 15, 2014
Association of higher methotrexate dose with lymphoproliferative disease onset in rheumatoid arthritis patients.
Journal: Arthritis care & research
Published: July 14, 2013
Effective treatment with rituximab for primary thrombotic thrombocytopenic purpura complicated with multiple cerebral infarctions
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Published: April 14, 2012
Last Updated: 09/26/2026